About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
R
POEMS Syndrome Management
By
MyCancerHaven
FEATURING
Ravi Vij
,
David Dingli
By
MyCancerHaven
FEATURING
Ravi Vij
,
David Dingli
279 views
May 7, 2024
0 Comments
Login to view comments.
Click here to Login
Featured Video
24:35
Indy Hematology Review
Current Approaches in the Treatment of Myeloproliferative Neoplasms
Feat.
A. Tefferi
Featured Video
01:29
Incyte
Targeting CSF-1R to Manage Inflammation and Fibrosis in GVHD
Related Content
AUTOPLAY
ON
21:05
Louisville Hematology Highlights
Why Are Our Hematopoietic Stem Cells in the Bone Marrow?
Feat.
R. Gale
16:42
Insights from 2023 ASH Annual Meeting
ASH 2023 Summary: "The Best of Myeloma - Highlights & Key T…
Feat.
H. Hashmi
17:52
Indy Hematology Review
2024 Updates on Emerging & Current Treatment of Multiple Myeloma
Feat.
K. Anderson
20:17
Indy Hematology Review
Managing Amyloidosis in 2024: Diagnosis and Treatment
Feat.
M. Gertz
17:46
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Highlights in 1L MM - Quadruplet Therapies …
Feat.
A. Jakubowiak
19:08
Insights from 2023 ASH Annual Meeting
ASH 2023 Summary: "Practice Changing Updates in MM, SMM and MGU…
Feat.
R. Banerjee
19:24
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Updates on Managing Newly Diagnosed MM - In…
Feat.
P. Richardson
20:19
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "Highlights of Hematologic Malignancies - …
Feat.
A. Paulus
05:35
Saurabh Chhabra
Bispecifics & CAR-Ts in MM: How to Choose and How to Sequence
28:20
Indy Hematology Review
Managing Newly Diagnosed MM in 2024
Feat.
S. Usmani
09:51
i3 Health
MRD Testing in Leukemias: When Negativity Is a Positive Thing
Feat.
N. S. Raje
12:38
SOHO 2022 Tenth Annual Meeting
SOHO 2022 DEBATE: Bispecific Antibodies vs. CAR-T for R/R MM - Defen…
Feat.
S. Usmani
24:44
Indy Hematology Review
State of the Art in 2024: Emerging Therapies in Hematologic Malignan…
Feat.
R. Birhiray
14:09
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Summary: "Multiple Myeloma Highlights and Clinical P…
Feat.
H. Hashmi
06:19
Insights from 2023 ASH Annual Meeting
Dara-KRd in NDMM Without ASCT: Final Analysis of a Ph2 Trial
Feat.
B. Derman
13:43
Houston Methodist Hospital
Lung Involvement in Amyloidosis
Feat.
H. Huang
35:37
University of Colorado Division of Hematology
2024 Updates on Multiple Myeloma Treatment
Feat.
D. Sherbenou
03:42
Moffitt Cancer Center
Multiple Myeloma: What You Need to Know About New FDA Approvals of C…
Feat.
D. Hansen
26:46
Samer Al Hadidi
CAR-Ts Earlier in MyelomaTherapy?: What We Learned From the Recent F…
49:01
Scripps MD Anderson Cancer Center
Multiple Myeloma: Current Summary of the Treatment Landscape
Feat.
R. Lu